Has Your Cancer Spread Through the Use of a Power Morcellator?
Contact us. We can help.
The U.S. Food and Drug Administration (FDA) has issued a safety communication discouraging the use of laparoscopic power morcellator for the removal of the uterus (Hysterectomy) or uterine fibroids (Myomectomey) in women because, based on an analysis of currently available data, it poses a risk of spreading unsuspected cancerous tissue, notably uterine sarcomas beyond the uterus.
If you’ve been through this procedure and have had this happen to you, or suspect that it may have, you should speak with an experienced morcellator attorney as soon as possible. There are limits on the amount of time you have to file your case and if you wait too long, you may not be able to recover for what you have suffered through the use of this device.
The FDA urged doctors to stop using power morcellators for uterine fibroid removal, and earlier this month an FDA advisory committee split on deciding whether to recommend severe power morcellator safety warnings or a total power morcellator recall. The committee agreed, however, that there was no known way to make morcellation for uterine fibroid removal safe.
Contact us today.
Strick Schnasse Lawyers are reviewing potential lawsuits for women throughout the United States who have been diagnosed with the spread of aggressive cancer following a laparoscopic hysterectomy or uterine fibroid removal surgery where a power morcellator was used.